InvestorsHub Logo
Followers 26
Posts 665
Boards Moderated 0
Alias Born 04/30/2019

Re: Cardiologymd post# 229745

Sunday, 11/24/2019 11:52:16 AM

Sunday, November 24, 2019 11:52:16 AM

Post# of 424029

This presented lab value changes has nothing to do with Vascepa.



“NOTHING” to do with Vascepa? You wouldn’t know that unless you ran trials to show the synergistic effects of these 3 medications. We already know Vascepa has synergistic effects with one of the drugs listed.

Primary Prevention wasn’t stat significant.

So who cares? The data clearly shows it was trending towards being stat significant.

Run more trials if you’d like to “prove it” sure... it would be nice to have multiple trials showing how great V is.

But waiting for the trials to finish before approving for primary will cost lives. That is a fact.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News